Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Yoshiteru Eikyu is active.

Publication


Featured researches published by Yoshiteru Eikyu.


Bioorganic & Medicinal Chemistry Letters | 1995

Synthesis and evaluation of nitro 5-deazaflavins as novel bioreductive antitumor agents

Tetsuji Kawamoto; Yoshihiro Ikeuchi; Junko Hiraki; Yoshiteru Eikyu; Kazue Shimizu; Masaki Tomishima; Kiyoshi Bessho; Fumio Yoneda; Yuji Mikata; Mamiko Nishida; Kenji Ikehara; Takuma Sasaki

Abstract A series of nitro 5-deazaflavins, 5-deazaflavins possessing a nitro group at C(6)–C(9) position, has been designed and synthesized as a novel class of bioreductive nitrohetero-aromatic compounds and their cytotoxicities towards L1210 and KB cells were evaluated. It has been found that the nitro 5-deazaflavins undergo one electron reduction on the nitro group and undergo two electrons or “(net) hydride” reduction on the C(5)-C(4a)-C(10a)-N(1) redox system. They showed much more potent antitumor activities than the other 5-deazaflavins bearing no nitro group. These results suggest that an activation of nitro group by biological one electron reduction is crucial for an expression of cytotoxicity.


Bioorganic & Medicinal Chemistry Letters | 2003

Structure-Based de novo design of non-nucleoside adenosine deaminase inhibitors

Tadashi Terasaka; Isao Nakanishi; Katsuya Nakamura; Yoshiteru Eikyu; Takayoshi Kinoshita; Nobuya Nishio; Akihiro Sato; Masako Kuno; Nobuo Seki; Kazuo Sakane

We searched for non-nucleoside inhibitors of adenosine deaminase by rational structure-based de novo design and succeeded in the discovery of 1-(1-hydroxy-4-phenyl-2-butyl)imidazole-4-carboxamide (FR221647: K(i)=5.9 microM to human ADA) as a novel inhibitor with moderate activity and good pharmacokinetics compared with the known inhibitors pentostatin and EHNA.


Bioorganic & Medicinal Chemistry Letters | 1995

Evaluation of differential hypoxic cytotoxicity and electrochemical studies of nitro 5-deazaflavins

Tetsuji Kawamoto; Yoshihiro Ikeuchi; Junko Hiraki; Yoshiteru Eikyu; Kazue Shimizu; Masaki Tomishima; Kiyoshi Bessho; Fumio Yoneda; Yuji Mikata; Mamiko Nishida; Kenji Ikehara

Abstract Cytotoxicities of nitro 5-deazaflavins were evaluated in vitro towards hypoxic and oxic Chinese hamster cells (V79). 6-Nitro and 8-nitro derivatives were generally more toxic towards hypoxic cells than oxic cells, showing marked hypoxic selectivity. In contrast, 7-nitro and 9-nitro derivatives showed no significant hypoxic selectivity. Electrochemical study using cyclic voltammetry (CV) revealed that 6-nitro and 8-nitro derivatives generate a stable two electrons reduction product as well as a stable one electron reduction product and that 7-nitro and 9-nitro derivatives afford an unstable one electron reduction product. These results strongly support that not solely electron affinity but also stability of the one electron reduction products is crucial for the differential hypoxic cytotoxicities of nitro 5-deazaflavins.


Archive | 1994

NEW CEPHEM COMPOUNDS

Kohji Kawabata; Hirofumi Yamamoto; Yoshiteru Eikyu; Shinya Okuda; Hisashi Takasugi


Archive | 1998

AROYL-PIPERAZINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS TACHYKININ ANTAGONISTS

Hiroshi Miyake; Kazuhiko Take; Shinji Shigenaga; Hidenori Azami; Hiroshi Sasaki; Yoshiteru Eikyu; Kazuo Nakai; Junya Ishida; Takashi Manabe; Nobukiyo Konishi; Tadashi Terasaka


Archive | 2007

N-hydroxyacrylamide compounds

Fumiyuki Shirai; Hideo Tsutsumi; Hiromichi Itani; Yoshihiro Kozuki; Yoshiteru Eikyu; Taro Masunaga


Archive | 1997

3-pyrazoliomethylcephem compounds as antimicrobial agents

Kohji Kawabata; Shinya Okuda; Kohei Kishi; Yoshiteru Eikyu; Hisashi Takasugi


Archive | 2001

1-(2-methoxybenzyl)-3-benzhydrylpiperazines as tachykinin antagonists

Kazukiko Take; Chiyoshi Kasahara; Shinji Shigenaga; Hidenori Azami; Yoshiteru Eikyu; Kazuo Nakai; Masataka Morita


Chemical & Pharmaceutical Bulletin | 1992

Hybridization of oligodeoxynucleotide with redox coenzyme model ; synthesis and properties of thymidine decamers covalently linked to 5-deazaflavin

Yoshiteru Eikyu; Yoshinori Nakamura; Taishin Akiyama; Fumio Yoneda; Kiyoshi Tanaka; Kaoru Fuji


Bioorganic & Medicinal Chemistry Letters | 2003

Corrigendum to “Structure-Based de novo design of non-nucleoside adenosine deaminase inhibitors” [Bioorg. Med. Chem. Lett. 13 (2003) 1115]☆

Tadashi Terasaka; Isao Nakanishi; Katsuya Nakamura; Yoshiteru Eikyu; Takayoshi Kinoshita; Nobuya Nishio; Akihiro Sato; Masako Kuno; Nobuo Seki; Kazuo Sakane

Collaboration


Dive into the Yoshiteru Eikyu's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Hideo Tsutsumi

Tokyo Institute of Technology

View shared research outputs
Researchain Logo
Decentralizing Knowledge